Unintended events following immunization with MMR: a systematic review (Q28202106)

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Safety of routine childhood vaccinations. An epidemiological review

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Relation between experimental and non-experimental study designs. HB vaccines: a case study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

An evaluation of measles, mumps and rubella vaccine in a population of Yorkshire infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

A randomised single blind trial of a combined mumps measles rubella vaccine to evaluate serological response and reactions in the UK population

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Serological evaluation of a measles, mumps, and rubella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Clinical and laboratory studies of combined live measles, mumps, and rubella vaccines using the RA 27/3 rubella virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Evaluation of a trivalent measles, mumps, rubella vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

A population-based study of measles, mumps, and rubella vaccination and autism

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilance centres and pasteur-mérieux sérums et vaccins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021

Safety reporting in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900271-8

7 January 2021